5- methyl- 8- (4- methyl- piperazin- 1- yl)- 4- oxo- 4H- chromene- 2- carboxylic acid (4-morpholin-4-yl-phenyl)amide
a selective 5-HT1B receptor radioligand for positron emission tomography (PET); structure in first source
Also Known As:
(11C)AZ10419369
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Ashina, Messoud:
2 articles
(01/2019 - 01/2018)
|
| 2. | Deen, Marie:
2 articles
(01/2019 - 01/2018)
|
| 3. | Hougaard, Anders:
2 articles
(01/2019 - 01/2018)
|
| 4. | Dyssegaard, Agnete:
1 article
(01/2019)
|
| 5. | Hansen, Hanne Demant:
1 article
(01/2019)
|
| 6. | Knudsen, Gitte Moos:
1 article
(01/2019)
|
| 7. | Schain, Martin:
1 article
(01/2019)
|
| 8. | Hansen, Hanne D:
1 article
(01/2018)
|
| 9. | Keller, Sune H:
1 article
(01/2018)
|
| 10. | Knudsen, Gitte M:
1 article
(01/2018)
|
Related Diseases
Related Drugs and Biologics